• Ibotenic Acid Workflows for Circuit Neuroscience

  2026-08-17

  Learn how Ibotenic acid can support controlled regional neuronal perturbation, glutamatergic signaling studies, and neurodegenerative disease model development. The workflow also shows how to pair this broad NMDA receptor agonist strategy with circuit-specific behavioral assays inspired by recent mechanical allodynia research.

• URB597 in Cell Assay Workflows

  2026-08-16

  Learn how URB597 (SKU A4372; KDS-4103) can support controlled FAAH and endocannabinoid experiments while minimizing solvent, timing, and interpretation errors in cell-based workflows. This scenario-driven guide separates product-backed facts from practical assay recommendations for viability, proliferation, and cytotoxicity studies.

• GRE Combination Suppresses Melanogenesis via CREB/MITF

  2026-08-15

  The reference study evaluates glabridin, resveratrol, and ellagic acid as a combined GRE composition rather than as isolated natural actives. Across melanogenesis, antioxidant, and inflammation-related assays, GRE produced the strongest overall response and was associated with suppression of the CREB/MITF regulatory axis, providing a mechanistic framework for pigmentation regulation research.

• Staurosporine Workflows for Tumor Microenvironment

  2026-08-14

  Build reproducible apoptosis, kinase-signaling, angiogenesis, and 3D collagen assays with Staurosporine as a broad pharmacologic benchmark. This workflow translates type III collagen findings into practical tumor-microenvironment experiments while emphasizing dose control, matrix context, and interpretation limits.

• Chloramphenicol and the New Plasmid Logic of AMR

  2026-08-14

  Chloramphenicol is more than a selection antibiotic: it can serve as a controlled entry point for studying plasmid maintenance, resistance-gene localization, and horizontal transfer. This translational perspective connects molecular biology workflows with recent carbapenem-resistant Enterobacter cloacae findings.

• TGF-β, Sca-1, and Mammary Cell Plasticity

  2026-08-13

  Remšík and colleagues showed that TGF-β signaling dynamically regulates Sca-1 expression, lineage plasticity, and tumor-initiating potential in mouse pre-neoplastic and mammary cancer cell models. The study distinguishes endogenous Smad2/3/4-dependent repression from the Smad2/3-independent response to exogenous TGF-β, providing an important framework for interpreting stem-cell markers in early tumor evolution.

• Neomycin Sulfate as a Mechanistic Probe

  2026-08-13

  Neomycin sulfate is more than an aminoglycoside antibiotic: it is a structured perturbation tool for RNA, DNA, and ion-channel assays. This article connects its molecular mechanisms with microbiome and immune-study design to clarify what each readout can—and cannot—prove.

• Isorhamnetin: From PI3K/Akt to Translation

  2026-08-12

  A translational perspective on how Isorhamnetin links oxidative-stress control, apoptosis, endoplasmic-reticulum homeostasis, and PI3K/Akt signaling in oocyte maturation research.

• Toremifene for Breast Cancer: 20 Years of Evidence

  2026-08-12

  This review synthesizes two decades of clinical experience with toremifene and positions it as an evidence-supported endocrine option for postmenopausal patients with hormone-sensitive breast cancer. Its main contribution is the integration of efficacy, safety, tissue-selective estrogen activity, and distinct pharmacokinetic considerations rather than a claim of universal superiority over tamoxifen or aromatase inhibitors.

• Kanamycin Sulfate in RNA Research Workflows

  2026-08-11

  Kanamycin Sulfate is a water-soluble antibiotic best known for bacterial selection and aminoglycoside mechanism studies. This article places A2516 within a broader RNA-production workflow, showing how rigorous selection controls and emerging circRNA purification methods can improve experimental interpretation.

• miR-24-3p/Sp1/PI3K Axis in Heart Failure

  2026-08-11

  A Cellular Signalling study identifies miR-24-3p as a regulator of doxorubicin-induced cardiac injury through direct repression of Sp1 and disruption of PI3K signaling. Its rat and H9c2 cell experiments connect this axis with apoptosis, oxidative stress, and impaired cardiac function, while miR-24-3p silencing produced protective effects that may guide future heart-failure research.

• Silymarin Experimental Workflows and Use Cases

  2026-08-10

  Turn milk thistle extract into a controlled research variable with solubility-aware preparation, dose-ranging, and orthogonal readouts. This workflow guide shows how to use Silymarin across oxidative stress, hepatocellular carcinoma, metabolic, and antiviral experiments while avoiding mixture, vehicle, and assay-interference pitfalls.

• CHK1 Inhibition in ER/PR-Stratified Breast Cancer

  2026-08-09

  The reference study shows that CHK1 inhibition has different therapeutic consequences across breast cancer subtypes defined by ER, PR, and HER2 status. Its key contribution is a subtype-aware treatment framework: CHK1 inhibition enhanced adriamycin sensitivity in ER−/PR−/HER2− models but showed greater single-agent activity in ER+/PR+/HER2− models.

• METTL16–SENP3–LTF Axis in HCC Ferroptosis

  2026-08-08

  Wang et al. identify a METTL16–SENP3–LTF signaling axis that protects hepatocellular carcinoma cells from ferroptosis by reducing the labile iron pool. The study connects m6A-dependent RNA regulation with SUMO-related protein stability and shows why this pathway may influence HCC progression and ferroptosis-based treatment strategies.

• AZD8055: Practical mTOR Inhibitor Guide

  2026-08-07

  AZD8055 is an ATP-competitive mTOR inhibitor for studying catalytic mTOR activity, mTORC1 signaling, mTORC2 signaling, cancer-cell proliferation, and related metabolic responses. It is suited to controlled preclinical workflows, but its poor aqueous solubility, limited clinical benefit, and lack of directly matched paper evidence here make it unsuitable for water-based formulation or clinical efficacy conclusions.

8551 records 2/571 page Previous Next 12345 下5页 Last page